184 related articles for article (PubMed ID: 20670370)
1. Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets.
Getz TM; Dangelmaier CA; Jin J; Daniel JL; Kunapuli SP
J Thromb Haemost; 2010 Oct; 8(10):2283-93. PubMed ID: 20670370
[TBL] [Abstract][Full Text] [Related]
2. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion.
Watanabe Y; Ito M; Kataoka Y; Wada H; Koyama M; Feng J; Shiku H; Nishikawa M
Blood; 2001 Jun; 97(12):3798-805. PubMed ID: 11389019
[TBL] [Abstract][Full Text] [Related]
4. The Pro33 isoform of integrin beta3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases.
Vijayan KV; Liu Y; Sun W; Ito M; Bray PF
J Biol Chem; 2005 Jun; 280(23):21756-62. PubMed ID: 15826939
[TBL] [Abstract][Full Text] [Related]
5. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
Aburima A; Wraith KS; Raslan Z; Law R; Magwenzi S; Naseem KM
Blood; 2013 Nov; 122(20):3533-45. PubMed ID: 24100445
[TBL] [Abstract][Full Text] [Related]
6. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets.
Klages B; Brandt U; Simon MI; Schultz G; Offermanns S
J Cell Biol; 1999 Feb; 144(4):745-54. PubMed ID: 10037795
[TBL] [Abstract][Full Text] [Related]
7. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
Riondino S; Gazzaniga PP; Pulcinelli FM
Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
[TBL] [Abstract][Full Text] [Related]
8. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets.
Bauer M; Retzer M; Wilde JI; Maschberger P; Essler M; Aepfelbacher M; Watson SP; Siess W
Blood; 1999 Sep; 94(5):1665-72. PubMed ID: 10477691
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells.
Satpathy M; Gallagher P; Lizotte-Waniewski M; Srinivas SP
Exp Eye Res; 2004 Oct; 79(4):477-86. PubMed ID: 15381032
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
Wraith KS; Magwenzi S; Aburima A; Wen Y; Leake D; Naseem KM
Blood; 2013 Jul; 122(4):580-9. PubMed ID: 23699602
[TBL] [Abstract][Full Text] [Related]
11. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.
Paul BZ; Daniel JL; Kunapuli SP
J Biol Chem; 1999 Oct; 274(40):28293-300. PubMed ID: 10497186
[TBL] [Abstract][Full Text] [Related]
12. Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: The role of phosphatidylinositol 3 kinase/AKT pathway.
Signorello MG; Leoncini G
Biochimie; 2014 Oct; 105():182-91. PubMed ID: 25068972
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by Rho-kinase and protein kinase C of myosin phosphatase is involved in thrombin-induced shape change of megakaryocytic leukemia cell line UT-7/TPO.
Yazaki A; Tamaru S; Sasaki Y; Komatsu N; Wada H; Shiku H; Nishikawa M
Cell Signal; 2005 Mar; 17(3):321-30. PubMed ID: 15567063
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: role of MLC phosphorylation.
Wang P; Verin AD; Birukova A; Gilbert-McClain LI; Jacobs K; Garcia JG
Am J Physiol Lung Cell Mol Physiol; 2001 Dec; 281(6):L1472-83. PubMed ID: 11704544
[TBL] [Abstract][Full Text] [Related]
15. P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation.
Toth-Zsamboki E; Oury C; Cornelissen H; De Vos R; Vermylen J; Hoylaerts MF
J Biol Chem; 2003 Nov; 278(47):46661-7. PubMed ID: 14500714
[TBL] [Abstract][Full Text] [Related]
16. Citron kinase, a Rho-dependent kinase, induces di-phosphorylation of regulatory light chain of myosin II.
Yamashiro S; Totsukawa G; Yamakita Y; Sasaki Y; Madaule P; Ishizaki T; Narumiya S; Matsumura F
Mol Biol Cell; 2003 May; 14(5):1745-56. PubMed ID: 12802051
[TBL] [Abstract][Full Text] [Related]
17. Carbachol-induced rabbit bladder smooth muscle contraction: roles of protein kinase C and Rho kinase.
Wang T; Kendig DM; Smolock EM; Moreland RS
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1534-42. PubMed ID: 19794111
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation.
Retzer M; Essler M
Cell Signal; 2000 Oct; 12(9-10):645-8. PubMed ID: 11080616
[TBL] [Abstract][Full Text] [Related]
19. Tonic protein kinase A activity maintains inactive beta2 integrins in unstimulated neutrophils by reducing myosin light-chain phosphorylation: role of myosin light-chain kinase and Rho kinase.
Chilcoat CD; Sharief Y; Jones SL
J Leukoc Biol; 2008 Apr; 83(4):964-71. PubMed ID: 18218860
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase.
Suzuki Y; Yamamoto M; Wada H; Ito M; Nakano T; Sasaki Y; Narumiya S; Shiku H; Nishikawa M
Blood; 1999 May; 93(10):3408-17. PubMed ID: 10233893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
